ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

SAGE Sage Therapeutics Inc

13,71
0,605 (4,62%)
04 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Sage Therapeutics Inc SAGE NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,605 4,62% 13,71 01:00:08
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
13,46 13,45 13,97 13,94 13,105
mais cotações »

Notícias Recentes

Data Hora Fonte Título
25/04/202407:30BWSage Therapeutics Announces First Quarter 2024 Financial..
17/04/202407:30BWSage Therapeutics Announces Topline Results from Phase 2..
11/04/202407:30BWSage Therapeutics to Report First Quarter 2024 Financial..
28/02/202408:30BWSage Therapeutics to Present at Upcoming March Investor..
14/02/202408:30BWSage Therapeutics Announces Fourth Quarter and Full Year..
31/01/202408:30BWSage Therapeutics to Report Fourth Quarter and Full Year..
08/01/202408:32BWSage Therapeutics to Provide Business Updates at 42nd Annual..
08/01/202408:30BWSage Therapeutics Announces Changes to Board of Directors
02/01/202408:30BWSage Therapeutics to Present at the 42nd Annual J.P. Morgan..
14/12/202308:30GLOBEZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for..
08/11/202308:30BWSage Therapeutics to Present at Upcoming November Investor..
07/11/202308:30BWSage Therapeutics Announces Third Quarter 2023 Financial..
24/10/202307:30BWSage Therapeutics to Report Third Quarter 2023 Financial..
18/10/202308:10DJNSage Therapeutics Gets FDA Orphan Designation for SAGE-718..
18/10/202307:30BWSage Therapeutics Announces U.S. Food and Drug..
06/09/202307:30BWSage Therapeutics to Present at Upcoming September Investor..
31/08/202307:30BWSage Therapeutics Implements Strategic Reorganization to..
08/08/202308:51IHMARKETNEWSTuesday’s Wall Street Highlights: Novo Nordisk, RingCentral,..
07/08/202309:18DJNSage Therapeutics Shares Slide Premarket After Zurzuvae MDD..
07/08/202308:26IHMARKETNEWSMonday’s Wall Street Highlights: Berkshire Hathaway, Tesla,..
07/08/202308:23DJNSage Therapeutics Mulls Job, Pipeline Cuts After FDA..
07/08/202307:30BWSage Therapeutics Announces Second Quarter 2023 Financial..
04/08/202323:45BWSage Therapeutics to Host Business Update Webcast and..
04/08/202323:42BWFDA Approves ZURZUVAE™ (zuranolone), the First and Only Oral..
05/06/202307:30BWSage Therapeutics to Present at the Goldman Sachs 44th..

Seu Histórico Recente

Delayed Upgrade Clock